Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Compliance With Nasdaq's New $5 Million Market Value Listing Standard

Rhea-AI Summary

Healthcare Triangle (Nasdaq: HCTI) completed the issuance of an aggregate 12,546,540 common shares on July 24, 2026 tied to two previously shareholder-approved legacy M&A transactions: the Teyame AI LLC acquisition and a Share Exchange Agreement with SecureKloud Technologies.

According to Healthcare Triangle, these issuances increased total common shares outstanding to 14,644,322 as of July 28, 2026. The larger float raised the company’s estimated Market Value of Listed Securities to about $23,870,244, based on a $1.63 closing share price, supporting its position relative to Nasdaq’s new $5 million minimum MVLS continued listing standard. The company noted that this is not a formal confirmation of compliance by Nasdaq, which makes its own determinations.

Positive

• 12,546,540 new shares issued to complete legacy M&A deals
• Total shares outstanding increased to 14,644,322 as of July 28, 2026
• Estimated MVLS of about $23.9 million vs. new $5 million Nasdaq minimum

Negative

• Large issuance of 12,546,540 new shares implies substantial shareholder dilution

News Explained

The July 24 issuance is complete: adding 12,546,540 common shares increases HCTI’s total share count and reduces existing holders’ percentage ownership absent offsetting changes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Common shares outstanding increase to 14,644,322 following the closing of two previously approved transactions, providing added cushion under Nasdaq's newly effective Market Value of Listed Securities (MVLS) requirement

PLEASANTON, Calif., July 29, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare and life sciences organizations, today reported that, on July 24, 2026, it completed the issuance of an aggregate of 12,546,540 shares of common stock in connection with two previously shareholder-approved transactions: the closing of its acquisition involving Teyame AI LLC and related parties (the "Teyame Transaction"), and a Share Exchange Agreement with SecureKloud Technologies Ltd. Following these issuances, the Company's total shares of common stock outstanding as of the close of business on July 28, 2026 was 14,644,322.

Supporting Compliance With Nasdaq's New Continued Listing Standard

On July 22, 2026, the U.S. Securities and Exchange Commission approved a new Nasdaq continued listing requirement establishing a minimum Market Value of Listed Securities ("MVLS") of $5 million, applicable to all companies listed on Nasdaq.

The increase in HCTI's outstanding share count resulting from the Teyame Transaction and SecureKloud Share Exchange (together, the "Legacy Transactions") meaningfully increases the Company's Market Value of Listed Securities. As of July 28, 2026 the Company's MVLS was approximately $23,870,244, based on a closing price of the Company's sock of $1.63 per share on such date, providing the Company with a substantially strengthened compliance position under the new standard.

This press release does not constitute confirmation from Nasdaq of the Company's compliance status under the new MVLS requirement; compliance determinations are made by Nasdaq based on the Company's daily closing bid price and total shares listed.

Management Commentary

David Ayanoglou, Chief Financial Officer of Healthcare Triangle, said:

"The completion of the Legacy Transactions marks an important step in HCTI's growth strategy. These issuances also meaningfully strengthen our position under Nasdaq's new listing standard, giving our shareholders added confidence in the Company's continued listing on the Nasdaq Global Market."

About Healthcare Triangle, Inc. (Nasdaq: HCTI)

Healthcare Triangle, Inc. delivers advanced digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare providers, payers, and life sciences organizations. HCTI strengthens healthcare delivery through enhanced security, compliance, data analytics, and operational efficiency.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the federal securities laws, including statements regarding HCTI's Market Value of Listed Securities, continued Nasdaq listing compliance, and the effects of the Teyame Transaction and SecureKloud Share Exchange. Forward-looking statements are identified by words such as "intends," "estimates," "anticipates," "believes," "expects," "plans," "target," and similar expressions and their negatives. These statements are based on current expectations and assumptions and are subject to risks and uncertainties — including fluctuations in HCTI's stock price, changes in shares outstanding, and Nasdaq's application of its listing standards — that could cause actual results, including HCTI's continued listing status, to differ materially. Compliance with Nasdaq's MVLS requirement is determined by Nasdaq and depends on the Company's closing bid price and total shares listed over time, which are outside the Company's control. For additional discussion of risks, see HCTI's Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission at www.sec.gov, particularly the section entitled "Risk Factors." The Company undertakes no obligation to update these statements except as required by law.

Investor Relations & Capital Markets Contact
Healthcare Triangle, Inc. (Nasdaq: HCTI)
1-800-617-9550
ir@healthcaretriangle.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/healthcare-triangle-completes-share-issuances-relating-to-legacy-ma-transactions-strengthening-compliance-with-nasdaqs-new-5-million-market-value-listing-standard-302837309.html

SOURCE Healthcare Triangle, Inc.

FAQ

What did Healthcare Triangle (HCTI) announce about new share issuances on July 29, 2026?

Healthcare Triangle announced it issued 12,546,540 new common shares on July 24, 2026. According to Healthcare Triangle, these shares relate to previously approved legacy transactions involving Teyame AI LLC and a Share Exchange Agreement with SecureKloud Technologies, increasing its total shares outstanding.

How many Healthcare Triangle (HCTI) shares are now outstanding after the legacy transactions?

After completing the legacy transactions, Healthcare Triangle reports 14,644,322 common shares outstanding as of July 28, 2026. According to Healthcare Triangle, this higher share count directly reflects the 12,546,540 shares issued for the Teyame Transaction and the SecureKloud Share Exchange.

How does the new Nasdaq $5 million MVLS standard affect Healthcare Triangle (HCTI)?

Nasdaq’s new rule requires a minimum $5 million Market Value of Listed Securities for continued listing. According to Healthcare Triangle, its post-issuance MVLS was approximately $23,870,244 on July 28, 2026, which supports its position relative to this updated requirement.

What is Healthcare Triangle’s (HCTI) estimated Market Value of Listed Securities after the share issuance?

Healthcare Triangle estimates its MVLS at about $23,870,244 as of July 28, 2026. According to Healthcare Triangle, this figure is based on a $1.63 closing share price and the updated share count following the legacy M&A-related issuances.

Does the July 29, 2026 update confirm Healthcare Triangle’s (HCTI) compliance with Nasdaq’s MVLS rule?

The update does not formally confirm Nasdaq compliance for Healthcare Triangle. According to Healthcare Triangle, only Nasdaq determines compliance, using daily closing bid price and total listed shares, although the company cites an MVLS significantly above the $5 million minimum.